Animal StudyPubMed ID: 21212381·2011

BPC-157 Prevents and Reverses Brain Ischemic Injury in Stroke Model

Sikiric P, Seiwerth S, Mise S, et al.

Stroke, 2011 · n = 44

Key finding

BPC-157 reduced infarct volume by 53% (p<0.001), improved neurological score by 67%, and enhanced cerebral blood flow recovery.

Summary

BPC-157 administration reduced infarct volume and improved neurological recovery in transient middle cerebral artery occlusion (tMCAO) rat stroke model.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

BPC-157L2

A gastric pentadecapeptide studied extensively in animal models for tissue healing, gut protection, and cytoprotective properties. Despite over 100 preclinical studies, human clinical data remains extremely limited.

More research on BPC-157

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

Sports Health · 2025 · Review

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study

Alternative Therapies in Health and Medicine · 2025 · Human Pilot

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity

Pharmaceuticals · 2024 · Review

Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

Frontiers in Pharmacology · 2021 · Review

Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway

Scientific Reports · 2020 · Animal Study